{"transactions":[{"id":4392751,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-03-09T22:08:22.000Z","date":"2017-03-08","kind":"other","acquired":false,"shares":19732767,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 8, 2017, WFD Ventures Fund II, L.P. distributed, on a pro-rata basis and without consideration, to its economic partners 19,732,767 of the Issuer's shares, including 625,954 of such shares to WFD-GP II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":43000,"source":{"system":"sec-edgar","filing":"0000899243-17-007012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317007012/doc4.xml","form_type":"4"}},{"id":4409805,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Warrants","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":525618,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable as of the date hereof."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":3.59,"expiration_date":"2018-07-21","underlying":"Ordinary Shares","underlying_shares":525618},"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4409804,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Warrants","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":686836,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Currently exercisable as of the date hereof."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":3.59,"expiration_date":"2017-07-31","underlying":"Ordinary Shares","underlying_shares":686836},"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4409803,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Ordinary Shares","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":248285,"price":7.6,"value":1886966.0,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects 248,285 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 277,333 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":19775767,"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4409802,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Ordinary Shares","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":525618,"price":3.59,"value":1886968.62,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":20024052,"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4409801,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Ordinary Shares","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":324440,"price":7.6,"value":2465744.0,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects 324,440 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 362,396 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":19498434,"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4409800,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Ordinary Shares","published_at":"2017-03-03T00:21:42.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":686836,"price":3.59,"value":2465741.24,"ownership":{"direct":false,"nature":"WFD Ventures Fund II, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by WFD Ventures Fund II, L.P. WFD Ventures Fund II, L.P. beneficially owned 19,136,038 ordinary shares following the transactions reported by the aforementioned Form 4/A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":19822874,"source":{"system":"sec-edgar","filing":"0000899243-17-006165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317006165/doc4.xml","form_type":"4"}},{"id":4503025,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":177969,"kind":"organization","name":"WFD Ventures Fund II, L.P.","position":2,"cik":"0001481972","reported_name":"WFD Ventures Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2017-01-04T21:01:18.000Z","date":"2017-01-03","kind":"other","acquired":false,"shares":2242664,"ownership":{"direct":false,"nature":"WFD Ventures Fund A, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Doyle is a managing director of WFD Ventures LLC, which is the managing member of WFD Ventures Fund A, LLC.  Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-000224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000089924317000224/doc4.xml","form_type":"4"}}]}